“…In fact, over 30% of small-molecule drugs contain residues of tailor-made AAs [ 2 , 6 , 7 , 8 ], while peptidomimetics and peptide class drugs are fully based on AAs [ 9 , 10 , 11 , 12 ]. Consequently, the interest in development of synthetic approached for the preparation of tailor-made AA is at an all-time high [ 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 ]. Over the last decade, transformations of chiral Ni(II) complexes of Schiff bases derived from tridentate ligands and AAs ( Scheme 1 ), have emerged as a leading methodology for asymmetric synthesis of tailor-made AAs [ 23 , 24 ].…”